✦ LIBER ✦

A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion

✍ Scribed by Jacob J. Lokich; Merrill J. Egorin; Brian E. Cohen; Murray M. Bern; Thomas E. Zipoli; Cheri Moore

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 507 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890101)63:1<46::aid-cncr2820630107>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of 5-fluorouracil administ

Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy

✍ James A. Martenson; Thomas G. Shanahan; Michael J. O'Connell; Charles D. Cobau; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

## BACKGROUND. This study was designed to assess the toxicity of pelvic radiation therapy, 5-fluorouracil (5-FU) administered by protracted venous infusion, and leucovorin. ## METHODS. Pelvic radiation therapy consisted of 50.4 -54 gray (Gy) administered in 28 -30 fractions. Systemic treatment

Phase II study of bisantrene administere

Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma

✍ Marschke, Robert F. ;Kvols, Larry K. ;Cullinan, Stephen A. ;Laurie, John A. ;Mai 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Eighteen ambulatory patients who had proven metastatic adenocarcinoma of the pancreas and measurable disease but no previous chemotherapy were treated with bisantrene given by constant central intravenous infusion over 72 hours at a total dose of 300 mg/m2 repeated every 3 to 4 weeks. No objective r

A Phase I trial of h-ras antisense oligo

A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

✍ C. Casey Cunningham; Jon T. Holmlund; Richard S. Geary; T. Jesse Kwoh; Andrew Do 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Phase I study of a 120-hour continuous i

Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: A pediatric oncology group study

✍ Green, Daniel M. ;Krischer, Jeffrey P. ;Bell, Beverly ;Brecher, Martin L. ;Cushi 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

## Abstract To determine the maximum tolerated dose of 5‐fluorouracil administered as a 120‐hour continuous intravenous infusion to pediatric patients, we performed a phase I study using a starting dosage of 900 mg/m^2^/day. The maximum tolerated dosage (MTD) was 1,100 mg/m^2^/day. At this dosage l

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views